{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:06:28Z","timestamp":1784009188679,"version":"3.55.0"},"posted":{"date-parts":[[2026,7,13]]},"group-title":"In Review","reference-count":65,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,30]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Cerebrovascular alterations are widely observed in both Alzheimer\u2019s Disease (AD) and primary tauopathies. Here, we hypothesized that mechanisms of cerebrovascular alterations are shared between AD and primary tauopathies. We performed single-nucleus RNA sequencing of\n                  <italic>postmortem<\/italic>\n                  human inferior temporal gyrus to characterize transcriptomic changes across cerebrovascular cell types in AD and primary tauopathies (Corticobasal Degeneration, Pick\u2019s disease, and Progressive Supranuclear Palsy). Differential gene expression analyses revealed disease-specific transcriptional programs across vascular cell populations. However, genes involved in the heat-shock response were consistently upregulated across all diseases, suggesting a conserved cerebrovascular stress response during neurodegeneration. We further identified marked cerebrovascular remodeling in AD relative to primary tauopathies, along with dysregulation of genes mapping to AD risk loci in endothelial cells. Transcriptomic findings were validated using tissue clearing, light-sheet microscopy, and immunofluorescence quantification of vascular markers. These results define a conserved vascular stress program alongside AD-specific remodeling, highlighting the vasculature as a therapeutic target in neurodegeneration.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10197270\/v1","type":"posted-content","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:12:16Z","timestamp":1783966336000},"source":"Crossref","is-referenced-by-count":0,"title":["Cerebrovascular Single-Nucleus RNA-Seq Reveals Heat Shock Activation and Vascular Remodeling in Alzheimer\u2019s Disease and Primary Tauopathies"],"prefix":"10.21203","author":[{"given":"L. Daniel","family":"Estrella","sequence":"first","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnali","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhila","family":"Gundavelli","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley H.","family":"Yang","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chancellor","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Pastika","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aicha","family":"Abdourahman","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tamm","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Yanamandra","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandani","family":"Romanul","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Liao","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Zhao","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Lin","sequence":"additional","affiliation":[{"name":"AbbVie Pte Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Srinivasa","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinge","family":"Wang","sequence":"additional","affiliation":[{"name":"AbbVie (United States)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annita","family":"Martin","sequence":"additional","affiliation":[{"name":"AbbVie (United States)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Asque","sequence":"additional","affiliation":[{"name":"AbbVie (United States)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Doering","sequence":"additional","affiliation":[{"name":"AbbVie Deutschland GmbH & Company KG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina S.","family":"Ried","sequence":"additional","affiliation":[{"name":"AbbVie Deutschland GmbH & Company KG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"Talanian","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taekyung","family":"Kwon","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya E.","family":"Woodbury","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena Y.","family":"Grinberg","sequence":"additional","affiliation":[{"name":"AbbVie Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergina","family":"Agastra","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek H.","family":"Oakley","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Hyman","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Serrano-Pozo","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Zwang","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeshna","family":"Das","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Bennett","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","article-title":"Cellular and pathological heterogeneity of primary tauopathies","volume":"16","author":"Chung D-E C","year":"2021","unstructured":"Chung, D.-E. C., Roemer, S., Petrucelli, L. & Dickson, D. W. Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener 16, 57 (2021).","journal-title":"Mol Neurodegener"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","article-title":"Cellular and pathological functions of tau","volume":"25","author":"Parra Bravo C","year":"2024","unstructured":"Parra Bravo, C., Naguib, S. A. & Gan, L. Cellular and pathological functions of tau. Nat Rev Mol Cell Biol 25, 845\u2013864 (2024).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina Y","year":"2016","unstructured":"Iturria-Medina, Y. et al. Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun 7, 11934 (2016).","journal-title":"Nat Commun"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne A","year":"2015","unstructured":"Montagne, A. et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296\u2013302 (2015).","journal-title":"Neuron"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne A","year":"2020","unstructured":"Montagne, A. et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581, 71\u201376 (2020).","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.20493","article-title":"Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study","volume":"57","author":"Ruitenberg A","year":"2005","unstructured":"Ruitenberg, A. et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57, 789\u2013794 (2005).","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s00330-014-3172-3","article-title":"Distinct perfusion patterns in Alzheimer\u2019s disease, frontotemporal dementia and dementia with Lewy bodies","volume":"24","author":"Binnewijzend MAA","year":"2014","unstructured":"Binnewijzend, M. A. A. et al. Distinct perfusion patterns in Alzheimer\u2019s disease, frontotemporal dementia and dementia with Lewy bodies. Eur Radiol 24, 2326\u20132333 (2014).","journal-title":"Eur Radiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.nicl.2016.08.001","article-title":"Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study","volume":"12","author":"Dopper EGP","year":"2016","unstructured":"Dopper, E. G. P. et al. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study. Neuroimage Clin 12, 460\u2013465 (2016).","journal-title":"Neuroimage Clin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1523\/JNEUROSCI.1230-20.2020","article-title":"Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid","volume":"40","author":"Albrecht D","year":"2020","unstructured":"Albrecht, D. et al. Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid. J Neurosci 40, 8573\u20138586 (2020).","journal-title":"J Neurosci"},{"key":"ref10","first-page":"100153","article-title":"Cerebral blood flow, tau imaging, and memory associations in cognitively unimpaired older adults","volume":"3","author":"Weigand AJ","year":"2022","unstructured":"Weigand, A. J., Hamlin, A. M., Breton, J. & Clark, A. L. Cerebral blood flow, tau imaging, and memory associations in cognitively unimpaired older adults. Cereb Circ Cogn Behav 3, 100153 (2022).","journal-title":"Cereb Circ Cogn Behav"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"fcaf249","DOI":"10.1093\/braincomms\/fcaf249","article-title":"Cerebral blood flow is associated with plasma and PET biomarkers of tau pathology in middle age","volume":"7","author":"Houck AL","year":"2025","unstructured":"Houck, A. L. et al. Cerebral blood flow is associated with plasma and PET biomarkers of tau pathology in middle age. Brain Commun 7, fcaf249 (2025).","journal-title":"Brain Commun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1523\/JNEUROSCI.0237-23.2023","article-title":"Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer\u2019s Disease","volume":"43","author":"Bryant A","year":"2023","unstructured":"Bryant, A. et al. Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer\u2019s Disease. J Neurosci 43, 4541\u20134557 (2023).","journal-title":"J Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archneur.1995.00540310076019","article-title":"Cerebral infarction in Alzheimer\u2019s disease is associated with severe amyloid angiopathy and hypertension","volume":"52","author":"Olichney JM","year":"1995","unstructured":"Olichney, J. M. et al. Cerebral infarction in Alzheimer\u2019s disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 52, 702\u2013708 (1995).","journal-title":"Arch Neurol"},{"key":"ref14","unstructured":"AD Progression Atlas. https:\/\/ad-progression-atlas.partners.org\/?page=home."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng GXY","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun 8, 14049 (2017).","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao Y","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42, 293\u2013304 (2024).","journal-title":"Nat Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data","volume":"8","author":"Wolock SL","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data. Cell Syst 8, 281\u2013291.e9 (2019).","journal-title":"Cell Syst"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","article-title":"A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk","volume":"603","author":"Yang AC","year":"2022","unstructured":"Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk. Nature 603, 885\u2013892 (2022).","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/hmg\/ddaa182","article-title":"Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer\u2019s disease","volume":"29","author":"Morabito S","year":"2020","unstructured":"Morabito, S., Miyoshi, E., Michael, N. & Swarup, V. Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer\u2019s disease. Hum Mol Genet 29, 2899\u20132919 (2020).","journal-title":"Hum Mol Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"Finak G","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol 16, 278 (2015).","journal-title":"Genome Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5281\/ZENODO.7314197","author":"Micha\u0142 Krassowski, Arts M","year":"2022","unstructured":"Micha\u0142 Krassowski, Arts, M., Lagger, C. & Max. krassowski\/complex-upset: v1.3.5. Zenodo https:\/\/doi.org\/10.5281\/ZENODO.7314197 (2022)."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu S","year":"2024","unstructured":"Xu, S. et al. Using clusterProfiler to characterize multiomics data. Nat Protoc 19, 3292\u20133320 (2024).","journal-title":"Nat Protoc"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","article-title":"GOSemSim: an R package for measuring semantic similarity among GO terms and gene products","volume":"26","author":"Yu G","year":"2010","unstructured":"Yu, G. et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics 26, 976\u2013978 (2010).","journal-title":"Bioinformatics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","article-title":"Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo","volume":"80","author":"Yanamandra K","year":"2013","unstructured":"Yanamandra, K. et al. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80, 402\u2013414 (2013).","journal-title":"Neuron"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead P","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci Rep 7, 16878 (2017).","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.27.577088","author":"Hoglund Z","year":"2024","unstructured":"Hoglund, Z. et al. Brain Vasculature Accumulates Tau and Is Spatially Related to Tau Tangle Pathology in Alzheimer\u2019s Disease. bioRxiv 2024.01.27.577088 (2024) doi:10.1101\/2024.01.27.577088."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e84112","DOI":"10.7554\/eLife.84112","article-title":"Tissue libraries enable rapid determination of conditions that preserve antibody labeling in cleared mouse and human tissue","volume":"12","author":"Zwang TJ","year":"2023","unstructured":"Zwang, T. J. et al. Tissue libraries enable rapid determination of conditions that preserve antibody labeling in cleared mouse and human tissue. Elife 12, e84112 (2023).","journal-title":"Elife"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs GG","year":"2020","unstructured":"Kovacs, G. G. et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140, 99\u2013119 (2020).","journal-title":"Acta Neuropathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack CR","year":"2024","unstructured":"Jack, C. R. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"Office of Rare Diseases neuropathologic criteria for corticobasal degeneration","volume":"61","author":"Dickson DW","year":"2002","unstructured":"Dickson, D. W. et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61, 935\u2013946 (2002).","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.24559","article-title":"Deep clinical and neuropathological phenotyping of Pick disease","volume":"79","author":"Irwin DJ","year":"2016","unstructured":"Irwin, D. J. et al. Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol 79, 272\u2013287 (2016).","journal-title":"Ann Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s43587-021-00123-6","article-title":"Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer\u2019s disease","volume":"1","author":"Serrano-Pozo A","year":"2021","unstructured":"Serrano-Pozo, A. et al. Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer\u2019s disease. Nat Aging 1, 919\u2013931 (2021).","journal-title":"Nat Aging"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the Dependency of Cellular Protein Levels on mRNA Abundance","volume":"165","author":"Liu Y","year":"2016","unstructured":"Liu, Y., Beyer, A. & Aebersold, R. On the Dependency of Cellular Protein Levels on mRNA Abundance. Cell 165, 535\u2013550 (2016).","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41467-022-28280-1","article-title":"Inferring protein expression changes from mRNA in Alzheimer\u2019s dementia using deep neural networks","volume":"13","author":"Tasaki S","year":"2022","unstructured":"Tasaki, S. et al. Inferring protein expression changes from mRNA in Alzheimer\u2019s dementia using deep neural networks. Nat Commun 13, 655 (2022).","journal-title":"Nat Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-017-0184-x","article-title":"Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk","volume":"12","author":"Efthymiou AG","year":"2017","unstructured":"Efthymiou, A. G. & Goate, A. M. Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener 12, 43 (2017).","journal-title":"Mol Neurodegener"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez C","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54, 412\u2013436 (2022).","journal-title":"Nat Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.cell.2024.08.019","article-title":"Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics","volume":"187","author":"Rexach JE","year":"2024","unstructured":"Rexach, J. E. et al. Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics. Cell 187, 5753\u20135774.e28 (2024).","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e23789","DOI":"10.1371\/journal.pone.0023789","article-title":"Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer\u2019s disease","volume":"6","author":"Biron KE","year":"2011","unstructured":"Biron, K. E., Dickstein, D. L., Gopaul, R. & Jefferies, W. A. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer\u2019s disease. PLoS One 6, e23789 (2011).","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00702-009-0226-9","article-title":"Evidence of angiogenic vessels in Alzheimer\u2019s disease","volume":"116","author":"Desai BS","year":"2009","unstructured":"Desai, B. S., Schneider, J. A., Li, J.-L., Carvey, P. M. & Hendey, B. Evidence of angiogenic vessels in Alzheimer\u2019s disease. J Neural Transm (Vienna) 116, 587\u2013597 (2009).","journal-title":"J Neural Transm (Vienna)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e13119","DOI":"10.1111\/bpa.13119","article-title":"Gliovascular alterations in sporadic and familial Alzheimer\u2019s disease: APOE3 Christchurch homozygote glioprotection","volume":"33","author":"Henao-Restrepo J","year":"2023","unstructured":"Henao-Restrepo, J. et al. Gliovascular alterations in sporadic and familial Alzheimer\u2019s disease: APOE3 Christchurch homozygote glioprotection. Brain Pathol 33, e13119 (2023).","journal-title":"Brain Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(90)91111-S","article-title":"Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer\u2019s disease","volume":"508","author":"Perlmutter LS","year":"1990","unstructured":"Perlmutter, L. S., Chui, H. C., Saperia, D. & Athanikar, J. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer\u2019s disease. Brain Res 508, 13\u201319 (1990).","journal-title":"Brain Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1997.tb48457.x","article-title":"Brain microvascular changes in Alzheimer\u2019s disease and other dementias","volume":"826","author":"Bu\u00e9e L","year":"1997","unstructured":"Bu\u00e9e, L., Hof, P. R. & Delacourte, A. Brain microvascular changes in Alzheimer\u2019s disease and other dementias. Ann N Y Acad Sci 826, 7\u201324 (1997).","journal-title":"Ann N Y Acad Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/BF00294246","article-title":"Altered angioarchitecture in selected areas of brains with Alzheimer\u2019s disease","volume":"79","author":"Fischer VW","year":"1990","unstructured":"Fischer, V. W., Siddiqi, A. & Yusufaly, Y. Altered angioarchitecture in selected areas of brains with Alzheimer\u2019s disease. Acta Neuropathol 79, 672\u2013679 (1990).","journal-title":"Acta Neuropathol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e70907","DOI":"10.1002\/alz.70907","article-title":"Mesoscopic vascular alterations in Alzheimer\u2019s disease","volume":"21","author":"Hyman M","year":"2025","unstructured":"Hyman, M. et al. Mesoscopic vascular alterations in Alzheimer\u2019s disease. Alzheimers Dement 21, e70907 (2025).","journal-title":"Alzheimers Dement"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"12683","DOI":"10.3390\/ijms232012683","article-title":"Physiological and Pathological Remodeling of Cerebral Microvessels","volume":"23","author":"Tregub PP","year":"2022","unstructured":"Tregub, P. P., Averchuk, A. S., Baranich, T. I., Ryazanova, M. V. & Salmina, A. B. Physiological and Pathological Remodeling of Cerebral Microvessels. Int J Mol Sci 23, 12683 (2022).","journal-title":"Int J Mol Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e14521","DOI":"10.1002\/alz.14521","article-title":"Pathological angiogenesis was associated with cerebrovascular lesion and neurodegeneration in Alzheimer\u2019s disease","volume":"21","author":"Gao F","year":"2025","unstructured":"Gao, F. et al. Pathological angiogenesis was associated with cerebrovascular lesion and neurodegeneration in Alzheimer\u2019s disease. Alzheimers Dement 21, e14521 (2025).","journal-title":"Alzheimers Dement"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13195-019-0534-8","article-title":"CSF evidence of pericyte damage in Alzheimer\u2019s disease is associated with markers of blood-brain barrier dysfunction and disease pathology","volume":"11","author":"Miners JS","year":"2019","unstructured":"Miners, J. S., Kehoe, P. G., Love, S., Zetterberg, H. & Blennow, K. CSF evidence of pericyte damage in Alzheimer\u2019s disease is associated with markers of blood-brain barrier dysfunction and disease pathology. Alzheimers Res Ther 11, 81 (2019).","journal-title":"Alzheimers Res Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ajpath.2021.07.003","article-title":"Interplay between Brain Pericytes and Endothelial Cells in Dementia","volume":"191","author":"Procter TV","year":"2021","unstructured":"Procter, T. V., Williams, A. & Montagne, A. Interplay between Brain Pericytes and Endothelial Cells in Dementia. Am J Pathol 191, 1917\u20131931 (2021).","journal-title":"Am J Pathol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-024-01423-w","article-title":"Amyloid \u03b2 oligomer induces cerebral vasculopathy via pericyte-mediated endothelial dysfunction","volume":"16","author":"Chen S","year":"2024","unstructured":"Chen, S. et al. Amyloid \u03b2 oligomer induces cerebral vasculopathy via pericyte-mediated endothelial dysfunction. Alzheimers Res Ther 16, 56 (2024).","journal-title":"Alzheimers Res Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.31083\/j.fbl2904136","article-title":"Interactions between Beta-Amyloid and Pericytes in Alzheimer\u2019s Disease","volume":"29","author":"Li Y-Y","year":"2024","unstructured":"Li, Y.-Y., Guo, D.-D., Duan, R.-N. & Li, Y. Interactions between Beta-Amyloid and Pericytes in Alzheimer\u2019s Disease. Front Biosci (Landmark Ed) 29, 136 (2024).","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCRESAHA.117.311054","article-title":"Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer A\u03b2 Peptides","volume":"121","author":"Park L","year":"2017","unstructured":"Park, L. et al. Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer A\u03b2 Peptides. Circ Res 121, 258\u2013269 (2017).","journal-title":"Circ Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"e180904","DOI":"10.1172\/JCI180904","article-title":"Retinal perivascular macrophages regulate immune cell infiltration during neuroinflammation in mouse models of ocular disease","volume":"134","author":"Sterling JK","year":"2024","unstructured":"Sterling, J. K. et al. Retinal perivascular macrophages regulate immune cell infiltration during neuroinflammation in mouse models of ocular disease. J Clin Invest 134, e180904 (2024).","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","article-title":"Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy","volume":"615","author":"Chen X","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023).","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/brain\/awad309","article-title":"Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology","volume":"147","author":"Hartnell IJ","year":"2024","unstructured":"Hartnell, I. J. et al. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain 147, 590\u2013606 (2024).","journal-title":"Brain"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000486200","article-title":"Extravascular CD3\u2009+\u2009T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study","volume":"18","author":"Merlini M","year":"2018","unstructured":"Merlini, M., Kirabali, T., Kulic, L., Nitsch, R. M. & Ferretti, M. T. Extravascular CD3\u2009+\u2009T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study. Neurodegener Dis 18, 49\u201356 (2018).","journal-title":"Neurodegener Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","article-title":"Regulation and function of the human HSP90AA1 gene","volume":"570","author":"Zuehlke AD","year":"2015","unstructured":"Zuehlke, A. D., Beebe, K., Neckers, L. & Prince, T. Regulation and function of the human HSP90AA1 gene. Gene 570, 8\u201316 (2015).","journal-title":"Gene"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cell.2014.01.037","article-title":"Hsp90-Tau complex reveals molecular basis for specificity in chaperone action","volume":"156","author":"Karag\u00f6z GE","year":"2014","unstructured":"Karag\u00f6z, G. E. et al. Hsp90-Tau complex reveals molecular basis for specificity in chaperone action. Cell 156, 963\u2013974 (2014).","journal-title":"Cell"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cell.2004.12.024","article-title":"Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone","volume":"120","author":"Zhao R","year":"2005","unstructured":"Zhao, R. et al. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 120, 715\u2013727 (2005).","journal-title":"Cell"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e70077","DOI":"10.1002\/alz.70077","article-title":"Fibrillar tau alters cerebral endothelial cell metabolism, vascular inflammatory activation, and barrier function in vitro and in vivo","volume":"21","author":"Guzm\u00e1n-Hern\u00e1ndez R","year":"2025","unstructured":"Guzm\u00e1n-Hern\u00e1ndez, R. & Fossati, S. Fibrillar tau alters cerebral endothelial cell metabolism, vascular inflammatory activation, and barrier function in vitro and in vivo. Alzheimers Dement 21, e70077 (2025).","journal-title":"Alzheimers Dement"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/s41467-023-37840-y","article-title":"Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy","volume":"14","author":"Hussong SA","year":"2023","unstructured":"Hussong, S. A. et al. Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy. Nat Commun 14, 2367 (2023).","journal-title":"Nat Commun"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1002\/alz.13821","article-title":"Proteomic changes in the human cerebrovasculature in Alzheimer\u2019s disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid","volume":"20","author":"Wojtas AM","year":"2024","unstructured":"Wojtas, A. M. et al. Proteomic changes in the human cerebrovasculature in Alzheimer\u2019s disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid. Alzheimers Dement 20, 4043\u20134065 (2024).","journal-title":"Alzheimers Dement"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"9766","DOI":"10.18632\/oncotarget.2870","article-title":"EMMPRIN\/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF","volume":"6","author":"Khayati F","year":"2015","unstructured":"Khayati, F. et al. EMMPRIN\/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF. Oncotarget 6, 9766\u20139780 (2015).","journal-title":"Oncotarget"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1182\/blood-2009-04-217380","article-title":"EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2","volume":"114","author":"Bougatef F","year":"2009","unstructured":"Bougatef, F. et al. EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood 114, 5547\u20135556 (2009).","journal-title":"Blood"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1242\/jcs.01061","article-title":"EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation","volume":"117","author":"Brantley-Sieders DM","year":"2004","unstructured":"Brantley-Sieders, D. M. et al. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J Cell Sci 117, 2037\u20132049 (2004).","journal-title":"J Cell Sci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"110567","DOI":"10.1016\/j.biopha.2020.110567","article-title":"Role of EFNA1 in tumorigenesis and prospects for cancer therapy","volume":"130","author":"Hao Y","year":"2020","unstructured":"Hao, Y. & Li, G. Role of EFNA1 in tumorigenesis and prospects for cancer therapy. Biomed Pharmacother 130, 110567 (2020).","journal-title":"Biomed Pharmacother"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10197270\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10197270\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:52:20Z","timestamp":1784008340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10197270\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":65,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10197270\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,7,13]]},"subtype":"preprint"}}